Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme

BACKGROUND: Insulin-degrading enzyme (IDE) is a widely studied zinc-metalloprotease implicated in the pathogenesis of type 2 diabetes mellitus, Alzheimer disease (AD) and varicella zoster virus infection. Despite more than six decades of research on IDE, progress has been hampered by the lack of wel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DelleDonne, Anthony, Kouri, Naomi, Reinstatler, Lael, Sahara, Tomoko, Li, Lilin, Zhao, Ji, Dickson, Dennis W, Ertekin-Taner, Nilufer, Leissring, Malcolm A
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2009
Schlagworte:
Methodology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2768702/
https://ncbi.nlm.nih.gov/pubmed/19835587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1326-4-39
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge